Whole cell biocatalysis is an important tool for pharmaceutical intermediates synthesis, although it is hindered by some shortcomings, such as high cost and toxicity of inducer, mass transfer resistance caused by cell membrane and side reactions. Whole-cell catalysis using N-acetyl-D-glucosamine 2-epimerase (EC 5.1.3.8) and N-acetyl-D-neuraminic acid (Neu5Ac) aldolase (EC 4.1.3.3) is a promising approach for the production of Neu5Ac, a potential precursor of many anti-viral drugs. A powerful catalyst was developed by packaging the enzymes in an engineered bacterium and using a safe temperature-induced vector. Since the mass transfer resistance and the side reactions were substantially reduced, a high Neu5Ac amount (191 mM) was achieved. An efficient method was also presented, which allows one-pot synthesis of Neu5Ac with a safe and economic manner. The results highlight the promise of large-scale Neu5Ac synthesis and point at a potential of our approach as a general strategy to improve whole-cell biocatalysis.
I
n light of the current pandemic threat and the emergence of oseltamivir resistance, development of effective anti-influenza drugs and related precursors is crucial 1, 2 . N-Acetyl-D-neuraminic acid (Neu5Ac) and its derivatives play significant roles in many physiological and pathological processes, such as cellular recognition and communication, bacterial and viral infections, and tumour metastasis [3] [4] [5] . Therefore they are potentially useful pharmaceutical molecules. For example, zanamivir (Neu5Ac2en, 2-deoxy Neu5Ac, Biota/Glaxo), a commercial derivative of Neu5Ac, has been used to inhibit the neuraminidases of influenza viruses A and B in clinical settings. This compound prevents influenza virus infections, such as those caused by the avian influenza virus H5N1 and the current H1N1 1, 6, 7 . However, the high price of Neu5Ac caused by its conventional method of production has impeded its industrial application.
Neu5Ac can be prepared from natural sources by hydrolysis 8 , enzymatic conversion [9] [10] [11] [12] , or chemical synthesis 13, 14 . Among these methods, enzymatic conversion catalyzed by N-acetyl-D-glucosamine (GlcNAc) 2-epimerase (EC 5.1.3.8) and Neu5Ac aldolase (EC 4.1.3.3) is preferred [9] [10] [11] [12] 15 , because of the high efficiency of the process and cheap substrates used (pyruvate and GlcNAc) 16, 17 . However, the enzymes must be partially or completely purified, and ATP is required to activate GlcNAc 2-epimerase; consequently the process is complicated and costly. In comparison with isolated enzymes, whole-cell catalysts can be more readily and inexpensively prepared and are particularly useful for multi-enzyme reactions or those that require cofactor regeneration [18] [19] [20] . Neu5Ac production using coupled whole-cell catalysts has been reported, but the product amount and reaction rate are much lower than enzymatic catalysis [21] [22] [23] [24] . This disadvantage of coupled whole-cell catalysts is largely due to the mass transfer resistance caused by cell membrane, which also exists in other previously reported whole-cell catalyses and has hindered their industrial applications 19 . It is notable that the reactions catalyzed by GlcNAc 2-epimerase and Neu5Ac aldolase were separately packaged in two types of cells in all the previous reports, where the reaction intermediate (N-acetyl-D-mannosamine, ManNAc) needs to penetrate between cells [21] [22] [23] [24] . Therefore, single cell packaging of the reactions would prevent the penetration of ManNAc and then largely reduce the mass transfer resistance. Moreover, packaging the reactions in a single cell would also simplify the operation.
The existence of side reactions is another factor leading to low efficiency of whole-cell catalyzed Neu5Ac production. Because living cells still have certain metabolic capabilities, the side reactions that occur during the whole-cell catalytic processes are generally more serious than those occur during enzymatic synthesis 19 . The more unwanted side reactions have become a crucial drawback of wholecell biocatalysis which may seriously hamper product purification and reduce the overall yield 19, 25 . In whole-cell catalyzed synthesis of Neu5Ac, both the substrates pyruvate and GlcNAc can be utilized by the cells, where pyruvate is the central branch point and GlcNAc serves as the carbon and nitrogen source 26 . Of the two substrates required for Neu5Ac synthesis, GlcNAc is relatively more expensive and is mainly transported into cells by the active transporter of the phosphotransferase system (PTS) with phosphorylation followed by mineralization 26 . Therefore, the elimination of PTS for GlcNAc should be effective in reducing the GlcNAc-related side reactions and the cost.
Chemical induction systems such as isopropyl b-D-1-thiogalactopyranoside (IPTG) induced system are frequently used for driving gene expression 27 . However, for applications such as development of organisms for use in food products and development of biocatalysts for therapeutic products, supplement of the toxic and expensive inducer for induction is undesirable 27, 28 . Temperature induction is considered as a good alternative of chemical induction for scaled-up production of therapeutic products using biocatalysis because of its safety, low cost, and ease of operation 27, 28 . Therefore, developing a biocatalyst based on temperature induction expression system would be beneficial to the industrialization of whole-cell catalyzed Neu5Ac production. Actually, a temperature induction vector named pBV220 has been successfully used in Neu5Ac production by coupled whole cells in our previous work 24 . With these considerations in mind, we constructed a whole-cell catalyst by genetic engineering. At first, a mutant of Escherichia coli K12 was constructed by elimination of the PTS for GlcNAc. Then, the two reactions catalyzed by GlcNAc 2-epimerase and Neu5Ac aldolase were packaged in the single cell of the mutant by co-expressing the slr1975 gene from Synechocystis sp. PCC6803 and the nanA gene from E. coli K12. A novel one-pot reaction method for Neu5Ac production was also developed with the catalyst (Fig. 1) . A series of whole-cell reactions were performed to investigate the advantages of the constructed catalyst and developed method.
Results
Construction of E. coli DT26/pBVNsS. To coexpress the slr1975 gene encoding GlcNAc 2-epimerase and the nanA gene encoding Neu5Ac aldolase in the same cell, pBVNsS was constructed using a temperature-induced expression vector pBV220 as described in the method ( Fig. 2A, Fig. S1 ). The construction was verified by restriction digest. To determine whether genes slr1975 and nanA could be coexpressed in E. coli cells, the constructed plasmid pBVNsS was introduced into E. coli K12 to form E. coli K12/pBVNsS. E. coli K12/ pBVNsS was then cultured in lysogenic broth (LB) and induced at 42uC, followed by SDS-PAGE analysis (Fig. 2B ). As controls, strains E. coli K12/pBV220 (E. coli K12 harbouring plasmid pBV220), E. coli K12/pBVN 24 , and E. coli K12/pBVS 24 were used. Figure 2B shows that the two proteins were coexpressed in the recombinant strain, which indicated that the construction of pBVNsS was successful.
To eliminate the catabolism of GlcNAc, the nagE gene was disrupted using homologous recombination as described in the method (Fig. 2C, Fig. S2 ). PCR was used to verify the disruption event of nagE gene using primer set PnagE-u plus PnagE-d. The result in Fig. 2D shows that the PCR using the primer set generated products of the expected sizes. The resulting mutant was named DT26. The desired strain E. coli DT26/pBVNsS was then constructed by transforming E. coli DT26 with pBVNsS ( Fig. 1) .
Reaction catalyzed by E. coli DT26/pBVNsS. To demonstrate the advantages of E. coli DT26/pBVNsS, various reaction solutions were prepared for Neu5Ac production (reaction A, E. coli DT26/pBVNsS; reaction B, E. coli K12/pBVNsS; and reaction C, E. coli K12/pBVN and E. coli K12/pBVS). Using 1 M pyruvate and 200 mM GlcNAc, Neu5Ac was formed. No ATP was added in any of the reactions. The Neu5Ac amount, average reaction rates, and yields were compared (Table 3 ). After induction, the enzyme activities of the different induced whole cells were also calculated and listed (Table 3 ). It was showed that E. coli DT26/pBVNsS produced 59.8 mM Neu5Ac in 48 h while E. coli K12/pBVNsS and the coupled whole cells (E. coli K12/pBVN and E. coli K12/pBVS) produced 36.8 and 25.1 mM Neu5Ac, respectively.
Time courses of Neu5Ac production in the three reaction solutions were also investigated and described in Fig. 3 . Figure 3 shows that the reaction rate of reaction A (1.4 mmol l 21 h 21 ) is much higher than that of reaction of B (1.0 mmol l 21 h
21
) and C (1.0 mmol l 21 h 21 ). It is also showed that the time of reactions A and B (24 h) is longer than that of reaction C (42 h) when the concentration of Neu5Ac increased. In reaction C, it appears as if Neu5Ac production is biphasic, with an early rapid rate and a later slower rate, which is consistent with our previous report 24 . However, this phenomenon cannot be observed in reactions A and B.
Figure 1 | One-pot bio-synthesis scheme of Neu5Ac production by the constructed whole-cell catalyst. The rounded rectangle indicates a cell of the engineered E. coli DT26, whose GlcNAc-specific PTS was eliminated to reduce side reactions about GlcNAc. The enzymes GlcNAc 2-epimerase (I) and Neu5Ac aldolase (II) were coexpressed in E. coli DT26 with a safe temperature-induced vector. The mass transfer resistance was mainly caused by the membrane permeation of substrate and product (the membrane penetration by the intermediate ManNAc does not exist). : Membrane affected by cetyltrimethylammonium bromide (CTAB) that was used to reduce the mass transfer resistance caused by membrane. : The indicated function, GlcNAc-specific PTS (III), was eliminated, which would reduce side reactions about GlcNAc. ATP (adenosine triphosphate) was supplied by the cell. Effect caused by nagE disruption. To investigate the effect of disruption of nagE, 1 M GlcNAc (almost the saturated concentration) was used in Neu5Ac production reactions. Figure 4 shows the time courses of Neu5Ac production by different types of reactions. E. coli DT26/pBVNsS synthesized 86.8 mM Neu5Ac in 60 h while E. coli K12/pBVNsS produced 38.0 mM Neu5Ac and coupled cells (E. coli K12/pBVN 1 E. coli K12/pBVS) produced 21.3 mM Neu5Ac.
Effect of surfactant on Neu5Ac production. To enhance the mass transfer of substrates and product, different surfactants were supplemented in Neu5Ac production reaction solutions, respectively. The result showed that the surfactant cetyltrimethylammonium bromide (CTAB) has the best effect on improving Neu5Ac production ( Fig. S5 ). Time courses of Neu5Ac producing reactions with/without CTAB are showed in Fig. 5 . It is showed that strain E. coli DT26/ pBVNsS could produce 191.9 mM Neu5Ac in reaction mixture containing CTAB, while only 75.2 mM Neu5Ac was synthesized in mixture without CTAB. Reaction kinetics. The kinetics of Neu5Ac production was also investigated to further understand the reasons leading to the above advantages. The apparent kinetic parameters were determined using Lineweaver-Burk plots as described in the method (Fig S1) 29, 30 . The K m ' values of reactions catalyzed by E. coli K12/pBVNsS, E. coli DT26/pBVNsS and E. coli DT26/pBVNsS supplemented with CTAB were 2.2, 3.3 and 4.5 times lower than that with the coupled cells, while the V max ' values were increased by 1.7, 1.2 and 2.3 times, respectively (Table 4 ). These results imply that a higher Neu5Ac production rate can be achieved using lower concentrations of substrates by packaging Neu5Ac aldolase and GlcNAc 2-epimerase in one cell, disrupting nagE and supplying the surfactant, which may weaken mass transfer resistance and eliminate side reactions. When we calculate the overall reaction efficiency, V max '/K m ', the reaction with E. coli DT26/pBVNsS (supplemented with CTAB) exhibited significantly enhanced bioconversion efficiency, with a 10-fold increase compared to the method using coupled cells.
Discussion
Use of whole-cell biocatalysts for the industrial synthesis of chemicals has been attracting much attention as an environment-friendly synthetic method 19 . However, there are still some problems should be taken into consideration (i.e. permeation of substrates across the cell membrane, side reactions causing degradation of products, accumulation of byproducts, etc.), which hinder the industrialization of whole-cell biocatalysis 19 . Neu5Ac is an important precursor of therapeutic chemicals, which can be produced by whole-cell biocatalysis 25 .
The two problems about substrate permeation and side reactions have seriously impeded the application of whole-cell biocatalysis in Neu5Ac production 25 . Therefore, the development of method to solve the problems is very important. Here, the permeation resistance was reduced by coexpressing slr1975 and nanA, which should avoid the transfer of the intermediate ManNAc. The nagE gene of E. coli K12 encoding the GlcNAc-specific PTS transporter (EIICBA Nag ) was also successfully knocked out to create the strain E. coli DT26 whose PTS mediated metabolism of GlcNAc was blocked (Fig. 2CD, Fig. S2 ). The strain should be advantageous as a host strain for Neu5Ac production from GlcNAc for the less side reactions about GlcNAc. Since Neu5Ac is a drug precursor, we also put safety as a key consideration. It was reported that the use of temperature induced expression vector was safe comparing with chemical-induced systems 31 . Induction by temperature shift is also superior to that by chemical stimulation when the biocatalytic production of therapeutic products is scaled-up, because the former is cheaper and easier to operate 28 . E. coli K12 is a nonpathogenic strain whose genetic background has been studied extensively, and its genome has been sequenced 32, 33 . Many methods to removing the endotoxin, which can cause pyrogenic and endotoxic shock reactions in mammals, were also developed 34 . Therefore the temperature induced vector pBV220 and E. coli K12 were used in this work.
As we expect, strain E. coli DT26/pBVNsS (reaction A) showed significant advantages compared to coupled cells (reaction C) and E. coli K12/pBVNsS (reaction B). In reaction B, an increase (of about 46.8%) in Neu5Ac amount compared to reaction C (Table 3 and Fig. 1 ). Both the Neu5Ac amount and Neu5Ac yield were greatly increased in reaction A compared to reaction B (about 1.5 fold; Table 3 ). The average rates of reactions B and A were 1.0 and 1.4 mmol l 21 h 21 , respectively, during the phase in which the yield increased (Table 3 ). It is reported that productivity of whole-cell biocatalysis is often severely compromised by cell membrane, and can be significantly enhanced by treating the cell membrane 35 . Therefore, it is logical to suggest that the elimination of membrane penetration by the intermediate might have accelerated the mass transfer and contributed to the increase of Neu5Ac amount. In addition, the nagE knockout destroyed the EIICBA Nag so that the amount of GlcNAc being phosphorylated and then consumed by the cells decreased. Thus, the amount of GlcNAc transported without phosphorylation, which serves as the substrate for GlcNAc 2-epimerase, increased. The relatively high substrate concentration should result in higher reaction rates and final amounts of Neu5Ac. The apparently improved Neu5Ac yield in the reaction A, where E. coli DT26/pBVNsS is used, might be due to the reduced consumption of GlcNAc.
We have previously reported that Neu5Ac production is likely biphasic by coupled cells (reaction C), with an early rapid rate and a later slower rate 24 . Here, we did not observe the phenomenon in reaction A or B. We initially speculated that this phenomenon was caused by cell lysis, and performed experiments (analyzed the supernatant obtained by centrifuging reaction mixture) to demonstrate this. However, the result showed that there was no obvious protein release which should be caused by cell lysis. As a phenomenon that existed in Neu5Ac production using coupled cells, it is logical to propose that this is related to the mass transfer of the intermediate ManNAc, and the elimination of mass transfer resistance of the intermediate ManNAc have led to the elimination of the later phase of slower rate.
It is considered that the use of a high concentration of pyruvate to drive Neu5Ac production is not ideal, because it is difficult to isolate Neu5Ac from reaction mixtures containing high concentrations of pyruvate 10, 11 . By eliminating the side reactions related to GlcNAc, it is expected that the substrate GlcNAc, which can be separated from Neu5Ac by a simple operation 10, 36 , could be used to drive Neu5Ac production. In addition, compared with pyruvate, the high GlcNAc concentration did not seriously inhibit the enzyme activities (Fig. S3) . Therefore, 1 M GlcNAc was used in the following reactions. As expected, the reaction with a high GlcNAc concentration and E. coli DT26/pBVNsS as the catalyst showed a higher yield and a higher Neu5Ac amount than other two reactions (Fig. 4) . The initial pyruvate concentration was also optimized based on the molar ratio of Neu5Ac to pyruvate when the reaction reached equilibrium for subsequent product isolation. Based on the result, 500 mM pyruvate was selected as the optimal concentration (Fig. S4) .
For small hydrophilic molecules (molecular mass , 600 Da), such as pyruvate and GlcNAc, the inner membrane of the cell is the primary barrier to mass transfer 35 . It was reported that permeabilizing the membrane using certain compounds such as surfactants and organic solvents could enhance the Neu5Ac producing rate 21, 23 . The presence of surfactants at a concentration below the critical micelle concentration (CMC) can enhance the permeability of the cell membrane without destroying it 35, 37 . After investigating the effects of different surfactants at different concentrations, 0.03% CTAB was used for whole-cell catalysis (Fig. S5 ). In comparison with the reaction without CTAB, the Neu5Ac amount and reaction rate increased by 154.7% (from 75 6 3.8 mM to 191 6 10.5 mM) and 1.5 times (from 2.1 mM h 21 to 5.3 mM h
21
), respectively (Fig. 5 ). This result shows that elimination of mass transfer can efficiently enhance the Neu5Ac production, and indicates that the mass transfer resistance caused by cell membrane is indeed a major obstacle of whole-cell biocatalytic Neu5Ac production.
It is notable that the effect of CTAB is similar to that caused by packaging the two enzymes in a single cell. As shown in Table 4 , both the methods can reduce the K m ' and increase the V max ', which suggest that similar factors were involved in them. It was reported that the apparent K m values of immobilized enzymes increased in most cases for the immobilizations increased the diffusion limitations 38 . Therefore, it is logical to suggest that reduction of diffusion limitations would reduce the apparent K m of enzymes. It was also reported that addition of surfactant can reduce the diffusion limitations caused by membrane 35 . Moreover, the penetration of ManNAc can be avoided by packaging the two enzymes in a single cell. It is not difficult to conclude that both the methods enhanced the reaction by improving the mass transfer.
In summary, a powerful engineered whole-cell catalyst (E. coli DT26/pBVNsS) was constructed in which Neu5Ac aldolase and GlcNAc 2-epimerase were coexpressed from a temperature-induced expression vector in a GlcNAc-specific PTS eliminated system. Using this catalyst, we developed an efficient process for the one-pot synthesis of Neu5Ac. The side reactions and mass transfer limitations due to the membrane barrier were greatly reduced in this process. In comparison with whole-cell catalysis using coupled cells, our process resulted in a much higher Neu5Ac amount (191 6 10.5 mM, 59.0 6 3.2 g l 21 ) and a greatly enhanced bioconversion efficiency (10 times greater than coupled cells). Since the expensive activator ATP, which is necessary in the free enzyme process, could be omitted, our process is highly attractive in terms of convenience, efficiency, and economy. Moreover, as mass transfer resistance caused by membrane is a ubiquitous reason which leads to low reaction rates of whole cell catalyses 35 , it is reasonable to suggest that our method is also useful in other similar biocatalyses, especially that referring multiple-step reactions.
Methods
Bacterial strains, plasmids and culture conditions. All the bacterial strains and plasmids used are listed in Table 1 . E. coli DH5a was used as host in general genetic manipulation. E. coli K12 from American Type Culture Collection (ATCC 25404) was used as the host strain for constructed recombinant plasmids. Synechocystis sp. PCC6803 was used as the source of gene slr1975, which encodes GlcNAc 2-epimerase. The gene encoding Neu5Ac aldolase was from plasmid pET15b-nanA 23 . Plasmid pBV220 was used in construction of recombinant plasmids 24 . All the genes used were initially cloned into pMD18-T (Takara Co., Ltd., Dalian, China) for sequencing. Plasmids pLOI2065, pKD46, and pFT-A were used in gene disruption 39 . LB medium (tryptone 1%, yeast extract 0.5%, NaCl 1%, pH 7.5) was used for growing E. coli cells 40 where ampicillin (0.1 g l 21 ) was added when necessary. E. coli strains were grown at 37uC if not indicated.
Genetic methods. Standard methods were used for restriction digestions, agarose gel electrophoresis, and isolation of plasmid and genomic DNA 40, 41 . Primers listed in Table 2 were used to amplify corresponding genes. Chromosomal integration of mutated genes was facilitated by pKD46 containing an arabinose-inducible Red recombinase 42 . Integrants were selected by using antibiotic resistance, screened for appropriate antibiotic resistance markers and phenotypic traits, and verified by analyses of PCR products and fermentation profiles. FRT (FLP recognition target)-flanked antibiotic resistance genes were deleted by using FLP recombinase 39, 42 .
Construction of pBVNsS. Recombinant PCR 43 was performed using primers RecA, RecB, RecC, and RecD. In the first round, the gene nanA (fragment AB) was amplified by PCR with primers RecA and RecB at an annealing temperature of 60uC using pET15b-nanA as the template. Similarly, the gene slr1975 (fragment CD) was obtained using primers RecC and RecD and pBVS as the template. After purification by gel extraction, a mixture of fragments AB and CD was used as the templates for the second round of PCR with primers RecA and RecD to obtain fragment AD (DNA fragment contain both nanA and slr1975). Both AD and pBV220 were digested with the restriction enzymes EcoRI and SalI. Ligation of the AD and pBV220 resulted in the co-expression plasmid pBVNsS ( Fig. 2A, Fig. S1 ).
Disruption of nagE. The nagE gene of E. coli K12 encoding the GlcNAc-specific PTS transporter (EIICBA Nag ) was knocked out to eliminate GlcNAc metabolism by using a method described by Causey et al. 39 . A single derivative of pMD18-T was selected in which the amplified nagE gene was oriented in the same direction as the lac promoter (pMD18-T-4639). The fragment between two Aor51HI sites of nagE was replaced by the SmaI fragment from pLOI2065 containing a tet gene flanked by FRT sites to produce pMD18-T-4740. Plasmid pMD18-T-4740 served as a template for the amplification of nagE::FRT-tet-FRT (3.4 kbp) with primers PnagE-u and PnagE-d. Amplified DNA was integrated into E. coli K12/pKD46 as described 39 to produce DT12. The tet gene was removed by using FLP recombinase, and the resulting strain was designated DT26 (Fig. 2C, Fig. S2 ).
Whole-cell catalyst preparation. One percent inoculum of the overnight culture of E. coli strain K12 containing plasmid pBVNsS, pBVN, or pBVS was inoculated in LB medium (containing 100 mg l 21 ampicillin), and incubated at 30uC with shaking for 2 h. The temperature was then increased to 42uC to induce the cells, and incubation was continued for 5 h with shaking. The cells were collected by centrifugation at 8,000 rpm for 5 min and then washed twice with 0.85% NaCl solution.
Whole-cell reactions. Erlenmeyer flasks (50 mL) were used in all the reactions in which Neu5Ac was produced. The reaction mixture (8 mL) contained 60 mM potassium phosphate buffer (PKB, pH 7.4), 10 mM MgCl 2 . It was incubated in a rotary shaker at 200 rpm and 30uC. Appropriate concentrations (below the critical micelle concentrations) of surfactants (Triton X-100, CHAPS, CTAB, and SDS) were added when necessary. Neu5Ac, ManNAc, GlcNAc, and pyruvate were analyzed as reported earlier 23 .
Kinetics for different types of biocatalytic reactions. Whole-cell biocatalytic reactions were performed with various substrate (GlcNAc) concentrations (100 mM, 200 mM, 300 mM, 400 mM, and 500 mM) in order to compare reaction kinetics for the three types of reaction systems (reaction with coupled cells as catalyst, reaction with E. coli K12/pBVNsS as catalyst, and reaction with E. coli DT26/pBVNsS as catalyst and containing 0.03% CTAB). In all the reactions, pyruvate concentration was 1 M, and the reaction rates were determined by calculating the Neu5Ac producing rate. Since all the reactions showed Michael-Menten kinetic patterns, Lineweaver-Burk plot analysis was performed for determining the apparent kinetic parameters (K m ', V max ', and V max '/K m ') which were analogous to those (K m , V max , and V max /K m ) for enzymatic reactions.
Analytical methods. The activities of Neu5Ac aldolase and GlcNAc 2-epimerase were assayed according to previous reports 12, 21 . One unit of enzyme activity of Neu5Ac aldolase was defined as the amount that produces 1 mmol of pyruvate per minute at 37uC. One unit of enzymatic activity of GlcNAc 2-epimerase was defined as the amount that produces 1 mmol of ManNAc per min at 32uC. The Bradford protein assay was used to determine the amount of total protein 44 . The concentrations of Neu5Ac, ManNAc, GlcNAc, pyruvate, and all the carbon sources were measured by high-performance liquid chromatography (HPLC, Agilent 1100 series, HewlettPackard), equipped with a Bio-Rad Aminex HPX-87H column (30037.8 mm) and a refractive index detector. Analysis was performed with a mobile phase of 10 mM H 2 SO 4 at a flow rate of 0.4 ml min 21 and at 55uC. 
